Financials
- Market Capitalization 8.63 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-8.97
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 991 | PCVX Vaxcyte, Inc. - Common Stock | 59.86 USD | -2.13% | -5.75% | +9.83% | +41.51% | 8.91 B USD | ||
| 1000 | ABVX Abivax SA - American Depositary Shares | 111.99 USD | -2.02% | -5.64% | -10.34% | +36.57% | 8.80 B USD | ||
| 1004 | IBRX ImmunityBio, Inc. - Common Stock | 8.02 USD | -4.52% | +2.17% | +14.57% | +242.74% | 8.50 B USD | ||
| 1022 | TGTX TG Therapeutics, Inc. - Common Stock | 54.77 USD | -1.70% | -0.63% | -0.18% | +88.73% | 8.38 B USD |